NEW DELHI: Medicines could face tighter quality checks not just at manufacturing units but throughout their journey to pharmacies and patients, with the Centre proposing to bring Good Storage and Distribution Practices (GSDP) under the Drugs Rules, 1945.The Union health ministry has proposed incorporating GSDP guidelines into the rules to ensure that the quality, safety and efficacy of pharmaceutical products are maintained from the manufacturer or importer to the point of supply to patients.The proposed framework seeks to cover every stage of the distribution chain, including procurement, purchasing, storage, transportation, distribution, documentation and record-keeping.The move is aimed at addressing risks that can compromise medicines after they leave manufacturing facilities, including deterioration due to improper storage conditions, contamination, mix-ups, falsification, diversion and unauthorised distribution.
Share your thoughts in the comments
Be respectful · TOI community guidelines
The guidelines, developed by the Central Drugs Standard Control Organisation (CDSCO), are expected to strengthen inspections and enforcement by central and state drug-control authorities. They will also require greater documentation, traceability and accountability among manufacturers, importers, wholesalers, distributors, stockists and other entities involved in the pharmaceutical supply chain.The proposal seeks to ensure that medicines retain their specified quality and environmental conditions during storage and transportation, rather than relying solely on quality checks conducted at the manufacturing stage.The ministry has invited objections and suggestions from stakeholders and members of the public on the proposed amendment.